Study of pakvashaya pertaining to purishaja udavarta with reference to investigation range of fecal calprotectin
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Assessment of pakvashaya is possible on the basis of investigation range of fecal calprotectin
研究概览
简要总结
This is a randomized parallel group placebo controlled trial to study effect of eranda taila on gut biomarker that is on fecal calprotectin. Purishaja udavarta vyadhi selected for the clinical observations for the purpose of the study after literature review. Considering the samprapti of purishaja udavarta the aushadhi like Eranda Taila is useful for sampratibhanga i.e.chikitsa. It is possible to access effect on gut biomarker range which is produced by the Eranda tail . Therefore, the study is planned to develop a new technique of assessment of the structures situated in pakvashaya by means of utilization of gut biomarker assessment. This study helps in early diagnosis of purishaja udavarta on basis of investigation range of fecal calprotectin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 40.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Selected 120 diagnosed patients of purishaja udavarta.
排除标准
- •Patients below 40 years and above 60 yearsAvirecya Patients taken non-steroidal anti-inflammatory drugs.
结局指标
主要结局
Assessment of pakvashaya is possible on the basis of investigation range of fecal calprotectin
时间窗: 3 weeks
次要结局
- 1.Relieving of Mala sang and reduction in sign and symptoms of purishaja udavarta vyadhi(2.Effect of Eranda taila on gut biomarkers)